Rose K Update
Recently Paul Rose and Ian Jennings (Rose K Chairman) completed a comprehensive world tour to promote the Rose K brand among our manufacturers and practitioners worldwide. With Rose K now represented in more than 60 countries, this trip saw Paul and Ian travel to USA, Canada, Argentina, Chile, Brazil, Germany, France, Switzerland, Italy, Great Britain, Poland, Finland, Russia, South Africa and Singapore.
In North America, Paul gave lectures in seven cities (Los Angeles, Calgary, Denver, Dallas, St Louis (University of Missouri, College of Optometry), Richmond and Raleigh-Durham). These lectures were well attended and enabled us to support the efforts of our North American manufacturer Blanchard Labs, as well as providing an excellant opportunity to educate contact lens fitters about the patient benefits of the Rose K lens in one of our largest markets.
On his travels, Paul also gave lectures in Strasborg (France), St Gallen and Bern (Switzerland), Amantea (Italy), Catania (Sicily), Warsaw (Medical University of Warsaw, Poland), Helsinki (Finland), Belo Horizonte and Goiania (Brazil) and in Buenos Aires (Argentina). Again these lectures were well attended (with standing room only in some) and provided good exposure for the attending practitioners as to the benefits of using Rose K lenses.
Aside from lecturing, Paul and Ian attended the first meeting of Rose K fitters and a symposium of Opthalmologists in Brazil, the annual BCLA (British Contact Lens Association) Conference in Birmingham and met with many of our existing maunfacturers. They also took the opportunity to meet with potential new manufacturers and distributors in many countries. Another aspect to their visits were contact lens fitting workshops, where Paul performed live Rose K fittings on keratoconus patients in St Louis (USA), Warsaw (Poland), Italy, Sicily and Birmingham (UK).
Our thanks to all those people who made Paul and Ian so welcome and contributed enormously to what was a very successful trip. We continue to strengthen our ties with existing manufacturers and distributors and build new relationships in a number of emerging markets, where keratoconus patients have very limited expertise and products available to them.